CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Novo Nordisk As Company Snapshot
Novo Nordisk As operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novo Nordisk As with three other pharmaceutical manufacturers in Europe: AstraZeneca PLC of UNITED KINGDOM (2020 sales of £20.59 billion [US$28.33 billion] of which 41% was Oncology), Lonza Group AG of SWITZERLAND (4.51 billion Swiss Francs [US$4.88 billion] of which 99% was Pharma&Biotech), and Merck KGaA which is based in GERMANY (17.53 billion Euros [US$20.34 billion] of which 43% was Life Science).

Sales Analysis. During the second quarter of 2021, sales at Novo Nordisk As totalled 33.04 billion Danish Kroner. This is an increase of 10.1% from the 30.01 billion Danish Kroner in sales at the company during the second quarter of 2020. During the first two quarters of 2021, sales totalled 66.85 billion Danish Kroner, which is 4.6% higher than through the first two quarters of 2020. During the year ended December of 2020, sales at Novo Nordisk As were 126.95 billion Danish Kroner (US$19.79 billion). This is an increase of 4.0% versus 2019, when the company's sales were 122.02 billion Danish Kroner. This was the third consecutive year of growth at Novo Nordisk As. Sales of Diabetes and Obesity saw an increase of 5.0% in 2020, from 102.84 billion Danish Kroner to 108.02 billion Danish Kroner. Not all segments of Novo Nordisk As experienced an increase in sales in 2020: sales of Biopharmaceuticals fell 1.3% to 18.93 billion Danish Kroner.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Novo Nordisk As
  Stock Performance Chart for Novo Nordisk As
 
  Stock Data: Recent Stock Performance:
  Current Price (10/15/2021): 658.00
(Figures in Danish Kroner)
1 Week 4.1%   13 Weeks 2.3%  
4 Weeks 18.4%   52 Weeks 45.5%  
 
Novo Nordisk As Key Data:
  Ticker: NOVOB Country: Denmark
  Exchanges: CPH OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 126,946,000,000
(Year Ending Jan 2021).
Employees: 44,723
  Currency: Danish Kroner Market Cap: 1,495,018,112,000
  Fiscal Yr Ends: December Shares Outstanding: 2,272,064,000
  Share Type: B Stamaktie Closely Held Shares: 659,310,686
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.